4‐phenylbutyric acid promotes hepatocellular carcinoma via initiating cancer stem cells through activation of PPAR‐α
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
4‐phenylbutyric acid promotes hepatocellular carcinoma via initiating cancer stem cells through activation of PPAR‐α
Authors
Keywords
-
Journal
Clinical and Translational Medicine
Volume 11, Issue 4, Pages -
Publisher
Wiley
Online
2021-05-01
DOI
10.1002/ctm2.379
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Roles of peroxisome proliferator-activated receptor α in the pathogenesis of ethanol-induced liver disease
- (2020) Fan-Ge Meng et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Inflammatory pathways in alcoholic steatohepatitis
- (2019) Bin Gao et al. JOURNAL OF HEPATOLOGY
- Keratin 23 Is a Peroxisome Proliferator‐Activated Receptor Alpha–Dependent, MYC‐Amplified Oncogene That Promotes Hepatocyte Proliferation
- (2019) Donghwan Kim et al. HEPATOLOGY
- From NASH to HCC: current concepts and future challenges
- (2019) Quentin M. Anstee et al. Nature Reviews Gastroenterology & Hepatology
- Epidemiological and etiological variations in hepatocellular carcinoma
- (2019) Evangelista Sagnelli et al. INFECTION
- Elafibranor: a potential drug for the treatment of nonalcoholic steatohepatitis (NASH)
- (2019) Menso J. Westerouen Van Meeteren et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Molecular actions of PPARα in lipid metabolism and inflammation
- (2018) Nadia Bougarne et al. ENDOCRINE REVIEWS
- β-catenin-activated hepatocellular carcinomas are addicted to fatty acids
- (2018) Nadia Senni et al. GUT
- Epidemiology and Management of Hepatocellular Carcinoma
- (2018) Laura Kulik et al. GASTROENTEROLOGY
- 4-phenylbutyric acid attenuates endoplasmic reticulum stress-mediated apoptosis and protects the hepatocytes from intermittent hypoxia-induced injury
- (2018) Liu Xin et al. Sleep and Breathing
- Chemical chaperone 4-phenyl butyric acid (4-PBA) reduces hepatocellular lipid accumulation and lipotoxicity through induction of autophagy
- (2017) Ashraf U. Nissar et al. JOURNAL OF LIPID RESEARCH
- Pyrazinamide-induced hepatotoxicity is alleviated by 4-PBA via inhibition of the PERK-eIF2α-ATF4-CHOP pathway
- (2017) Hong-li Guo et al. TOXICOLOGY
- ER retention is imposed by COPII protein sorting and attenuated by 4-phenylbutyrate
- (2017) Wenfu Ma et al. eLife
- Pemafibrate, a novel selective peroxisome proliferator-activated receptor alpha modulator, improves the pathogenesis in a rodent model of nonalcoholic steatohepatitis
- (2017) Yasushi Honda et al. Scientific Reports
- Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
- (2016) Vlad Ratziu et al. GASTROENTEROLOGY
- Modeling a human hepatocellular carcinoma subset in mice through coexpression of met and point-mutant β-catenin
- (2016) Junyan Tao et al. HEPATOLOGY
- Hepatocellular carcinoma
- (2016) Josep M. Llovet et al. Nature Reviews Disease Primers
- Long Noncoding RNA HULC Modulates Abnormal Lipid Metabolism in Hepatoma Cells through an miR-9-Mediated RXRA Signaling Pathway
- (2015) M. Cui et al. CANCER RESEARCH
- Phenylbutyric Acid: Simple Structure - Multiple Effects
- (2015) Magdalena Kusaczuk et al. CURRENT PHARMACEUTICAL DESIGN
- PPARα regulates tumor progression, foe or friend?
- (2015) Jiaming Gao et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- PPARα gene expression correlates with severity and histological treatment response in patients with non-alcoholic steatohepatitis
- (2015) Sven Francque et al. JOURNAL OF HEPATOLOGY
- Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease
- (2015) Michal Pawlak et al. JOURNAL OF HEPATOLOGY
- PPAR-α and glucocorticoid receptor synergize to promote erythroid progenitor self-renewal
- (2015) Hsiang-Ying Lee et al. NATURE
- Equol induces apoptosis in human hepatocellular carcinoma SMMC-7721 cells through the intrinsic pathway and the endoplasmic reticulum stress pathway
- (2014) Xiao-Lin Liang et al. ANTI-CANCER DRUGS
- Alterations of the human gut microbiome in liver cirrhosis
- (2014) Nan Qin et al. NATURE
- Peroxisome proliferator-activated receptor α, a potential therapeutic target for alcoholic liver disease
- (2014) Yue-Min Nan WORLD JOURNAL OF GASTROENTEROLOGY
- Early Detection, Curative Treatment, and Survival Rates for Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis: A Meta-analysis
- (2014) Amit G. Singal et al. PLOS MEDICINE
- Mesenchymal-transitioned cancer cells instigate the invasion of epithelial cancer cells through secretion of WNT3 and WNT5B
- (2013) Shinichiro Kato et al. CANCER SCIENCE
- Identification of Liver Cancer Progenitors Whose Malignant Progression Depends on Autocrine IL-6 Signaling
- (2013) Guobin He et al. CELL
- Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
- (2013) Bart Staels et al. HEPATOLOGY
- Activation of peroxisome proliferator activated receptor alpha ameliorates ethanol mediated liver fibrosis in mice
- (2013) Yue-Min Nan et al. Lipids in Health and Disease
- Clinical and Experimental Applications of Sodium Phenylbutyrate
- (2013) Tommaso Iannitti et al. Drugs in research & development
- Profound impact of gut homeostasis on chemically-induced pro-tumorigenic inflammation and hepatocarcinogenesis in rats
- (2012) Hui-Lu Zhang et al. JOURNAL OF HEPATOLOGY
- Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010
- (2012) Christopher J L Murray et al. LANCET
- Phenylbutyric acid protects against carbon tetrachloride-induced hepatic fibrogenesis in mice
- (2012) Jian-Qing Wang et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Activation of peroxisome proliferator activated receptor alpha ameliorates ethanol induced steatohepatitis in mice
- (2011) Lingbo Kong et al. Lipids in Health and Disease
- Ammonia control in children with urea cycle disorders (UCDs); Phase 2 comparison of sodium phenylbutyrate and glycerol phenylbutyrate
- (2011) Uta Lichter-Konecki et al. MOLECULAR GENETICS AND METABOLISM
- Endotoxin accumulation prevents carcinogen-induced apoptosis and promotes liver tumorigenesis in rodents
- (2010) Le-Xing Yu et al. HEPATOLOGY
- Phase 2 comparison of a novel ammonia scavenging agent with sodium phenylbutyrate in patients with urea cycle disorders: Safety, pharmacokinetics and ammonia control
- (2010) Brendan Lee et al. MOLECULAR GENETICS AND METABOLISM
- Target identification using drug affinity responsive target stability (DARTS)
- (2009) B. Lomenick et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hepatocyte Necrosis Induced by Oxidative Stress and IL-1α Release Mediate Carcinogen-Induced Compensatory Proliferation and Liver Tumorigenesis
- (2008) Toshiharu Sakurai et al. CANCER CELL
- Liver cancer: Descriptive epidemiology and risk factors other than HBV and HCV infection
- (2008) Shu-Chun Chuang et al. CANCER LETTERS
- Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities
- (2008) Inki Kim et al. NATURE REVIEWS DRUG DISCOVERY
- PPARα: Mechanism of species differences and hepatocarcinogenesis of peroxisome proliferators
- (2007) Frank J. Gonzalez et al. TOXICOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started